Dr. Rockey is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 Hawkins Dr
Iowa City, IA 52242Phone+1 319-353-7019Fax+1 319-356-1530
Education & Training
University of Iowa Hospitals and ClinicsResidency, Radiation Oncology, 2008 - 2012- University of Iowa Hospitals and ClinicsInternship, Internal Medicine, 2007 - 2008
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 2007
Certifications & Licensure
IA State Medical License 2007 - 2026- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- [F-18] Fluorothymidine PET/CT Imaging for Pelvic Cancers Start of enrollment: 2012 Oct 01
- A Phase I Trial of High-Dose Ascorbate in Glioblastoma Multiforme Start of enrollment: 2013 Apr 01
- Gemcitabine, Ascorbate, Radiation Therapy for Pancreatic Cancer, Phase I Start of enrollment: 2014 Jan 01
Publications & Presentations
PubMed
- 24 citationsIn vitro RNA SELEX for the generation of chemically-optimized therapeutic RNA drugsKevin T. Urak, Sabrina Shore, William M. Rockey, Shi-Jie Chen, Anton P. McCaffrey
Methods. 2016-07-01 - 70 citationsTargeted Inhibition of Prostate Cancer Metastases with an RNA Aptamer to Prostate-specific Membrane AntigenJustin P. Dassie, Luiza I. Hernandez, Gregory S. Thomas, Matthew E. Long, William M. Rockey
Molecular Therapy. 2014-11-01 - 27 citationsInterstitial rotating shield brachytherapy for prostate cancerQuentin Adams, Jinghzu Xu, Elizabeth K. Breitbach, X Li, Shirin A. Enger
Medical Physics. 2014-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
